Australia markets closed

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
As of 03:28PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.08M
Enterprise value 896.00k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.53
Price/book (mrq)0.29
Enterprise value/revenue 8.53
Enterprise value/EBITDA -0.16

Trading information

Stock price history

Beta (5Y monthly) 1.90
52-week change 3-80.20%
S&P500 52-week change 3-10.89%
52-week high 30.1010
52-week low 30.0100
50-day moving average 30.0228
200-day moving average 30.0309

Share statistics

Avg vol (3-month) 38.41k
Avg vol (10-day) 39.39k
Shares outstanding 559.09M
Implied shares outstanding 6N/A
Float 857.19M
% held by insiders 18.63%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Nov 2020
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 29 Nov 2022
Most-recent quarter (mrq)29 Nov 2022


Profit margin 0.00%
Operating margin (ttm)-1,898.18%

Management effectiveness

Return on assets (ttm)-41.88%
Return on equity (ttm)-42.66%

Income statement

Revenue (ttm)189.68k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)189.68k
Net income avi to common (ttm)-2.06M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)680.17k
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)4.81
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-1.98M
Levered free cash flow (ttm)-1.98M